|
|
|
|
| LEADER |
03123nam a22003615i 4500 |
| 001 |
000290749 |
| 005 |
20210929102502.0 |
| 007 |
cr nn 008mamaa |
| 008 |
170107s2016 gw | s |||| 0|eng d |
| 020 |
|
|
|a 9783319414218
|
| 024 |
7 |
|
|a 10.1007/978-3-319-41421-8
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Polymer Nanoparticles for Nanomedicines :
|b A Guide for their Design, Preparation and Development /
|c edited by Christine Vauthier, Gilles Ponchel.
|
| 250 |
|
|
|a 1st ed. 2016.
|
| 260 |
# |
# |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2016.
|
| 300 |
|
|
|a XXIX, 641 p. 115 illus., 80 illus. in color. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 505 |
0 |
|
|a Preface -- Introduction Part I: Polymer nanoparticles for in vivo applications: Progress on preparation methods and future challenges -- Nanoprecipitation process: From particlepreparation to in vivo applications -- Targeted Theragnostic Nanoparticles via Flash Nanoprecipitation: Principles of Materials Selection -- Preparation of polymer nanoparticles by the emulsification-solvent evaporation method: from Vanderhoff´s pioneer approach to recent adaptations -- Methods for the preparation of nanoparticles by polymerization -- Shape-controlled nanoparticles for drug delivery and targeting applications -- Physicochemical characterization of polymer nanoparticles: Challenges and present limitations -- Imaging polymer nanoparticles by means of transmission and scanning electron microscopy techniques -- Evaluating the interactions between proteins and components of the immune system with polymer nanoparticles -- Investigating interactions between nanoparticles and cells: internalization and intracellular trafficking -- Characterization of mucoadhesive interactions between nanoparticles and epithelial membranes -- Designing polymer nanoparticle nanomedicines: potential applications and challenges -- Selecting and designing polymers suitable for nanoparticles manufacturing -- Associating Drugs with Polymer Nanoparticles: A Challenge -- Drug delivery by nanoparticles: The Challenge of Controlled Release and Evaluation -- Interaction between nanoparticles and plasma proteins: effects on nanoparticle biodistribution and toxicity -- Toxicological aspects of polymer nanoparticles -- Theranostics: In Vivo -- Nanomedicines –A scientific toy or an emerging market? -- Regulatory perspective on the development of polymeric nanomaterials.
|
| 650 |
|
0 |
|a Pharmaceutical technology.
|
| 650 |
|
0 |
|a Pharmacy.
|
| 650 |
|
0 |
|a Proteomics.
|
| 650 |
|
0 |
|a Biomedical engineering.
|
| 650 |
1 |
4 |
|a Pharmaceutical Sciences/Technology.
|
| 650 |
2 |
4 |
|a Drug Safety and Pharmacovigilance.
|
| 650 |
2 |
4 |
|a Proteomics.
|
| 650 |
2 |
4 |
|a Biomedical Engineering/Biotechnology.
|
| 700 |
1 |
|
|a Vauthier, Christine.
|e editor.
|
| 700 |
1 |
|
|a Ponchel, Gilles.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|
| 900 |
|
|
|a Libro descargado a ALEPH en bloque (proveniente de proveedor)
|